Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Non-cash Items (2020 - 2025)

Historic Non-cash Items for Bio (TELA) over the last 6 years, with Q3 2025 value amounting to $1.7 million.

  • Bio's Non-cash Items rose 581.21% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 581.21%. This contributed to the annual value of $1.7 million for FY2024, which is 291.79% up from last year.
  • Latest data reveals that Bio reported Non-cash Items of $1.7 million as of Q3 2025, which was up 581.21% from $1.8 million recorded in Q2 2025.
  • Over the past 5 years, Bio's Non-cash Items peaked at $6.1 million during Q1 2021, and registered a low of $883728.0 during Q3 2021.
  • Moreover, its 5-year median value for Non-cash Items was $1.6 million (2023), whereas its average is $1.8 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first skyrocketed by 142435.22% in 2021, then tumbled by 6065.57% in 2022.
  • Quarter analysis of 5 years shows Bio's Non-cash Items stood at $3.0 million in 2021, then tumbled by 58.74% to $1.2 million in 2022, then grew by 29.81% to $1.6 million in 2023, then grew by 2.92% to $1.7 million in 2024, then grew by 3.16% to $1.7 million in 2025.
  • Its Non-cash Items was $1.7 million in Q3 2025, compared to $1.8 million in Q2 2025 and $1.7 million in Q1 2025.